American Heart Journal
Volume 154, Issue 3 , Pages 545-553 , September 2007

A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents

  • Edward L. Hannan, PhD

      Affiliations

    • University at Albany, State University of New York, Albany, NY
    • Corresponding Author InformationReprint requests: Edward L. Hannan, PhD, School of Public Health, University at Albany, State University of New York, One University Place, Rensselaer, NY, 12144-3456.
    • ,
  • Michael Racz, PhD

      Affiliations

    • New York State Department of Health, Albany, NY
    • ,
  • David R. Holmes, MD

      Affiliations

    • Mayo Clinic, Rochester, MN
    • ,
  • Samin Sharma, MD

      Affiliations

    • Mt Sinai Medical Center, New York, NY
    • ,
  • Stanley Katz, MD

      Affiliations

    • North Shore-LIJ Health System, Manhasset, NY
    • ,
  • Gary Walford, MD

      Affiliations

    • St Joseph's Hospital, Syracuse, NY
    • ,
  • Spencer B. King III, MD

      Affiliations

    • Fuqua Heart Center/Piedmont Hospital, Atlanta, GA
    • ,
  • Luther T. Clark, MD

      Affiliations

    • University Hospital of Brooklyn, Brooklyn, NY
    • ,
  • Robert H. Jones, MD

      Affiliations

    • Duke University Medical Center, Durham, NC

Received 26 June 2006 ,Accepted 28 May 2007.

References 

  1. New York State Department of Health . Adult Cardiac Surgery in New York State: 1993-1995. Available at: http://www.health.state.ny.us/nysdoh/consumer/heart/cabg935.pdf2005;Accessed May 8, 2006
  2. New York State Department of Health . Angioplasty in New York State: 1995 Report. Available at: http://www.health.state.ny.us/nysdoh/reports/report.htm2005;Accessed May 8, 2006
  3. New York State Department of Health. Adult Cardiac Surgery in New York State: 2001-2003. 2005. Available at: http://www.health.state.ny.us/nysdoh/consumer/heart/coronary.pdf, http://www.health.state.ny.us/nysdoh/heart/pdf/2001-2003_cabg.pdf. Accessed May 8, 2006.
  4. New York State Department of Health . Percutaneous Coronary Interventions in New York State: 2001-2003. Available at: http://www.health.state.ny.us/nysdoh/heart/pdf/pci_2001-2003.pdf2005;Accessed May 8, 2006
  5. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489–495
  6. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496–501
  7. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916–927
  8. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–706
  9. Versaci F, Gaspardone A, Tomai F, et al. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med. 1997;336:817–822
  10. Rankin JM, Spinelli JJ, Carere RG, et al. Improved clinical outcome after widespread use of coronary-artery stenting in Canada. N Engl J Med. 1999;341:1957–1965
  11. Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561–566
  12. Hannan EL, Racz MJ, Arani DT, et al. A comparison of short- and long-term outcomes for balloon angioplasty and coronary stent placement. J Am Coll Cardiol. 2000;36:395–403
  13. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  14. Holmes DR, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634–640
  15. Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109:1942–1947
  16. Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788–794
  17. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  18. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294:1215–1223
  19. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA. 2004;292:2727–2734
  20. Hermiller JB, Raizner A, Cannon L, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS trial. J Am Coll Cardiol. 2005;45:1206–1212
  21. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six- and 12-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38–42
  22. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  23. Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multi-center, randomized trial. Circulation. 2005;112:3306–3313[Epub 2005 Nov 14]
  24. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003;348:1537–1545
  25. Gershlick A, De Scheerder I, Chevalier B, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation. 2004;109:487–493
  26. Lansky AJ, Costa RA, Mintz GS, et al. Non–polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions. Angiographic follow-up of the DELIVER clinical trial. Circulation. 2004;109:1948–1954
  27. Heldman AW, Farhat N, Fry E, et al. Paclitaxel-eluting stent for cytostatic prevention of restenosis: PATENCY study follow-up. Am J Cardiol. 2002;90(Suppl 1):3H
  28. Katritsis DG, Karvouni E, Ionnidis JP. Meta-analysis comparing drug-eluting stents with bare-metal stents. Am J Cardiol. 2005;95:640–643
  29. Indolfi C, Pavia M, Angelillo IF. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol. 2005;95:1146–1152
  30. Ong AT, Aoki J, van Mieghem CA, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947–953
  31. Bavry AA, Kumbhani DJ, Helton TJ, et al. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary interventions? A meta-analysis. J Am Coll Cardiol. 2005;45:941–946
  32. Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation. 2002;106:1949–1956
  33. Tanabe K, Serruys PW, Grube E, et al. TAXUS III trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation. 2003;107:559–564
  34. Kastrati A, Mehilli J, vonBeckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165–171
  35. Goy JJ, Stauffer JC, Siegenthaler M, et al. A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXI trial. J Am Coll Cardiol. 2005;45:308–311
  36. Windecker S, Remondino A, Eberli FR, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med. 2005;353:663–670
  37. Morice MC, Colombo A, Meier J, et al. Sirolimus- vs. paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA. 2006;295:895–904
  38. Park KH, Park SW, Hong MK, et al. Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions. Catheter Cardiovasc Interv. 2006;67:589–594
  39. Ong AT, Aoki J, vanMieghem CA, et al. Comparison of short- (one month) and long-(twelve months) term outcomes of sirolimus-versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol. 2005;96:358–362
  40. Dibra A, Kastrati A, Mehilli J, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663–670
  41. Cosgrave J, Agostoni P, Iakovou I, et al. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiol. 2005;96:1663–1668
  42. Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294:819–825
  43. Lin DY, Wei LJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989;84:1074–1078
  44. Ellison P. Survival analysis using the SAS system. Cary (NC): The SAS Institute; 1995;
  45. Rosenbaum PR, Rubin DR. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–524
  46. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes for coronary artery bypass graft surgery vs. stent implantation. N Engl J Med. 2005;352:2174–2183

PII: S0002-8703(07)00455-3

doi: 10.1016/j.ahj.2007.05.017

American Heart Journal
Volume 154, Issue 3 , Pages 545-553 , September 2007

Article Tools

* Image Usage & Resolution